Cargando…

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers

Deutetrabenazine (Austedo, Teva Pharmaceuticals) is a deuterated form of tetrabenazine. It is the first deuterated drug to receive US regulatory approval and is approved for treatment of chorea in Huntington’s disease and tardive dyskinesia. Two oral single dose studies comparing deutetrabenazine (2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Frank, Bradbury, Margaret, Baillie, Thomas A., Stamler, David, Hellriegel, Edward, Cox, Donna S., Loupe, Pippa S., Savola, Juha‐Matti, Rabinovich‐Guilatt, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359938/ https://www.ncbi.nlm.nih.gov/pubmed/32155315 http://dx.doi.org/10.1111/cts.12754

Ejemplares similares

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect
por: Schneider, Frank, et al.
Publicado: (2020)

The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers
por: Schneider, F., et al.
Publicado: (2021)

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2017)

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis
por: Schneider, Frank, et al.
Publicado: (2022)

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

On crushing of deutetrabenazine tablets
por: Knebel, Helena, et al.
Publicado: (2021)

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
por: Claassen, Daniel O., et al.
Publicado: (2021)

Meta-research metrics matter: letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial
por: Jankovic, Joseph, et al.
Publicado: (2021)

Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016)

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial
por: Coffey, Barbara, et al.
Publicado: (2021)

Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study
por: Jankovic, Joseph, et al.
Publicado: (2023)

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
por: Frank, Samuel, et al.
Publicado: (2022)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
por: Hauser, Robert A., et al.
Publicado: (2022)

A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe
por: Cherniakov, Irina, et al.
Publicado: (2021)

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
por: Fernandez, Hubert H., et al.
Publicado: (2017)

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects
por: Schneider, Frank, et al.
Publicado: (2018)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Benign Presentation Following Massive Deutetrabenazine Overdose
por: Obadeyi, Oluseyi, et al.
Publicado: (2021)

Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering
por: Ha, Catherine A., et al.
Publicado: (2021)

Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010)

Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011)

Structural Mechanisms for VMAT2 inhibition by tetrabenazine
por: Dalton, Michael P., et al.
Publicado: (2023)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
por: Patel, Rikinkumar S., et al.
Publicado: (2019)

Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors
por: Nijenhuis, Cynthia M., et al.
Publicado: (2016)

Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009)

Dual Treatment of Hemichorea–Hemiballismus Syndrome with Tetrabenazine and Chemodenervation
por: Umeh, Chizoba C., et al.
Publicado: (2012)

Effect of Tetrabenazine on Motor Function in Patients with Huntington Disease
por: Ferrara, Joseph M., et al.
Publicado: (2012)

Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation
por: Ettouati, Laurent, et al.
Publicado: (2019)

Synthesis of Tetrabenazine and Its Derivatives, Pursuing Efficiency and Selectivity
por: Paek, Seung-Mann
Publicado: (2020)

Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease
por: Dean, Marissa, et al.
Publicado: (2018)

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease
por: Rabinovich‐Guilatt, L., et al.
Publicado: (2015)

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
por: Skor, Heather, et al.
Publicado: (2017)

Unique Case Reports of Tooth Sensitivity After Consuming Tetrabenazine
por: Daripa, Bob
Publicado: (2022)

Quadriparesis and dysarthria due to tetrabenazine therapy in a child with rheumatic chorea
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Enantioselective synthesis of (−)-tetrabenazine via continuous crystallization-induced diastereomer transformation
por: Kukor, Andrew J., et al.
Publicado: (2022)

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
por: Frank, Samuel
Publicado: (2010)

A case of tics presenting as chronic intractable cough successfully treated with tetrabenazine
por: Pawar, Deepak G., et al.
Publicado: (2015)

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin
por: Aguilar, Lourdes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_95t8ot1rgpkqh2ak9qba4tuks5